Pirfenidone for treating idiopathic
pulmonary fibrosis
Issued: April 2013
NICE technology appraisal guidance 282
guidance.
nice.
org.
uk/ta282
NICE has accredited the process used by the Centre for Health Technology Evaluation at NICE to
produce technology...
More
Pirfenidone for treating idiopathic
pulmonary fibrosis
Issued: April 2013
NICE technology appraisal guidance 282
guidance.
nice.
org.
uk/ta282
NICE has accredited the process used by the Centre for Health Technology Evaluation at NICE to
produce technology appraisals guidance.
Accreditation is valid for 5 years from September 2009 and
applies to guidance produced since June 2008 using the processes described in NICE s The guide to
the methods of technology appraisal (2008).
More information on accreditation can be viewed at
www.
nice.
org.
uk/accreditation
© NICE 2013
Less
